Nuvation Bio Inc. ("Nuvation Bio") (NYSE: NUVB), a global oncology company focused on tackling some of the toughest challenges in cancer treatment, today announced that the underwriters have exercised ...
NEW YORK, June 25, 2026 Nuvation Bio Inc. ("Nuvation Bio") (NYSE: NUVB), a global oncology company focused on tackling some of the toughest challenges in cancer treatment, today announced the pricing ...
Johnson & Johnson (NYSE:JNJ) held its second-quarter earnings conference call on Wednesday. Below is the complete transcript ...
Mission: Yozakura Family Season 2 English dub lands on Hulu today with all 12 first-cour episodes available simultaneously — ...
Texas pastor died from E. Coli after hospital bungled lab test, widow claims in lawsuit - Exclusive: ‘Hospitals are becoming ...
21d
Ligachem Bio Secures First Bio Sector Investment from National Growth Fund, Raises 500 Billion Won
Ligachem Bio has been selected as the first direct investment target in the bio sector by the National Growth Fund. This marks the first case in which ...
Work at the Biodiversity Research and Teaching Collections at Texas A&M inspired Tim R. '74, '77 and Judy '78 Turner to ...
Company to Showcase Integration of AI, Digital Batch Records, and Intelligent Robotics to Accelerate Pharmaceutical ManufacturingAGOURA HILLS, ...
Q2 2026 Earnings Call July 15, 2026 8:30 AM EDTCompany ParticipantsRyan KoorsJoaquin Duato - CEO & ChairmanJoseph Wolk ...
(NASDAQ: HYFT) filed a European patent application directed to the high-dimensional biological data architecture beneath its HYFT® Technology, ReefIQ™, and LensAI™, the model-agnostic context layer ...
We honor legendary Boston Herald reporter Danny Ventura and dive into the 2026 spring All-Scholastics, including which school ...
Diranersen demonstrated efficacy across all studied doses at 18 months, with consistent results across multiple prespecified clinical endpoints; the 60 mg dose ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results